What about those cholesterol-lowering drugs doctors prescribe to treat high LDL cholesterol?
What he found could change the treatments doctors choose to fight atherosclerosis. The data showed that inflammation markers were a stronger predictor for risk of future cardiovascular events and death than LDL cholesterol levels. In interpreting the findings, Ridker suggests that beyond statins, aggressive lipid-lowering and inflammation-inhibiting therapies might be a better way to reduce disease risk.
Others in the scientific community note that among the causes of chronic inflammation are several enduring problems, such as obesity, diabetes and its precursors, and increasing consumption of highly processed foods. They urge a focus on diet, exercise, and smoking cessation.
But Ridker’s research does confirm that inflammatory markers in the blood can be used to assess disease risk, and potentially to treat patients differently. With a keener assessment of risk, for example, it may change the calculations regarding bypass surgery.
What about those cholesterol-lowering drugs doctors prescribe to treat high LDL cholesterol? Years ago, Duane Graveline, a physician and astronaut, was diagnosed with high cholesterol and prescribed Lipitor, a cholesterol lowering drug. Several months later he was unable to recognize his family.